Loading clinical trials...
Loading clinical trials...
A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers
This study evaluates analgesic properties of midazolam compared to placebo and fentanyl. Each participant will receive all three drugs (midazolam, fentanyl, placebo) on three different occasions (study visits) and the effect on different pain stimuli will be tested.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
Yes
Schmerzdiagnostik / Clinical Research Unit
Vienna, Vienna, Austria
Start Date
December 1, 2015
Primary Completion Date
March 1, 2016
Completion Date
March 1, 2016
Last Updated
March 11, 2016
24
ACTUAL participants
Midazolam
DRUG
Fentanyl
DRUG
Isotonic saline
DRUG
Lead Sponsor
Wilhelminenspital Vienna
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions